Urinary Tract Infections (UTI) are difficult to diagnose. They often include vague symptoms and infections. Many individuals suffer from recurrent and chronic UTI infections and a misdiagnosis can lead to serious consequences. The traditional testing method, urine culture, misses up to 75% of all UTI-positive patients. Additionally, antibiotic resistance has made treatment of UTIs a much greater challenge. This is why it is crucial to accurately identify the infecting pathogens and exclude antibiotic resistance as quickly as possible.
AIM’s Real-Time PCR (polymerase chain reaction) for UTI pathogen identification, quantification and detection of antibiotic resistance can help clinicians properly and quickly get patients on the right treatment the first time.
AIM Labs can rapidly detect bacterial and fungal targets, eliminating the need for costly, inaccurate or time-consuming follow up testing.
PCR is a molecular technique used at AIM’s state-of-the-art laboratories and can be used to precisely analyze the genetic material of pathogens. Additionally, PCR is three to five times more sensitive than conventional culture. AIM’s UTI solution is one of the fastest available, reporting both pathogen identification and antibiotic resistance testing results within 12 to 24 hours of receiving the patient’s specimen.